Huadong Medicine Co., Ltd (000963.SZ)
CNY 36.19
(0.56%)
CNY 36.19
(0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 40.39 Billion | 37.71 Billion | 34.56 Billion | 33.68 Billion | 35.44 Billion | 30.66 Billion |
| Cost of Revenue | 27.85 Billion | 25.68 Billion | 23.95 Billion | 22.55 Billion | 24.08 Billion | 21.77 Billion |
| Gross Profit | 12.53 Billion | 12.03 Billion | 10.6 Billion | 11.13 Billion | 11.35 Billion | 8.88 Billion |
| Operating Expenses | 9.7 Billion | 8.71 Billion | 7.57 Billion | 7.88 Billion | 8.03 Billion | 5.87 Billion |
| Selling, General and Administrative Expenses | 7.8 Billion | 6.85 Billion | 5.93 Billion | 6.44 Billion | 6.35 Billion | 4.69 Billion |
| Research and Development Expenses | 1.27 Billion | 1.01 Billion | 979.64 Million | 926.72 Million | 1.07 Billion | 706.04 Million |
| Other Expenses | 20.53 Million | 840.26 Million | 654.13 Million | 513.85 Million | 603.38 Million | 481.52 Million |
| Cost and Expenses | 36.8 Billion | 34.39 Billion | 31.53 Billion | 30.44 Billion | 32.12 Billion | 27.65 Billion |
| Operating Income | 3.58 Billion | 3.06 Billion | 2.85 Billion | 3.47 Billion | 3.39 Billion | 2.9 Billion |
| Interest Expense | 144.2 Million | 125.1 Million | 72.49 Million | 68.63 Million | 107.19 Million | 114.93 Million |
| Income Tax Expense | 619.58 Million | 498.49 Million | 488.9 Million | 543.67 Million | 544.86 Million | 477.37 Million |
| Earnings before Tax | 3.46 Billion | 3.03 Billion | 2.82 Billion | 3.45 Billion | 3.47 Billion | 2.87 Billion |
| Net Income | 2.83 Billion | 2.49 Billion | 2.3 Billion | 2.81 Billion | 2.81 Billion | 2.26 Billion |
| Earnings Per Share Basic | 1.62 | 1.43 | 1.32 | 1.61 | 1.61 | 1.29 |
| Earnings Per Share Diluted | 1.62 | 1.43 | 1.32 | 1.61 | 1.61 | 1.29 |
| Weighted Average Shares Outstanding | 1.75 Billion | 1.74 Billion | 1.74 Billion | 1.74 Billion | 1.74 Billion | 1.75 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.75 Billion | 1.74 Billion | 1.74 Billion | 1.74 Billion | 1.74 Billion | 1.75 Billion |
| Gross Margin | 0.31 | 0.32 | 0.31 | 0.33 | 0.32 | 0.29 |
| EBIT Margin | 0.11 | 0.10 | 0.10 | 0.11 | 0.11 | 0.11 |
| Profit Margin | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 | 0.07 |
| EBITDA | 4.61 Billion | 4 Billion | 3.57 Billion | 3.98 Billion | 3.99 Billion | 3.2 Billion |
| Earnings Before Tax Margin | 0.09 | 0.08 | 0.08 | 0.10 | 0.10 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 10.51 Billion | 10.49 Billion | 10.35 Billion | 40.39 Billion | 10.15 Billion | 10 Billion |
| Cost of Revenue | 7.12 Billion | 7.09 Billion | 7.07 Billion | 27.85 Billion | 6.85 Billion | 6.79 Billion |
| Gross Profit | 3.39 Billion | 3.4 Billion | 3.27 Billion | 12.53 Billion | 3.29 Billion | 3.21 Billion |
| Operating Expenses | 2.2 Billion | 2.43 Billion | 2.19 Billion | 8.94 Billion | 2.6 Billion | 2.25 Billion |
| Selling, General and Administrative Expenses | 3.65 Billion | 2.09 Billion | 1.9 Billion | - | 2.2 Billion | 2.41 Billion |
| Research and Development Expenses | 305.55 Million | 338.49 Million | 281.63 Million | - | 406.09 Million | 282.38 Million |
| Other Expenses | -1.76 Billion | -29.55 Million | -3.9 Million | 20.53 Million | -3.34 Million | -7.13 Million |
| Cost and Expenses | 9.32 Billion | 9.53 Billion | 9.26 Billion | 36.8 Billion | 9.46 Billion | 9.05 Billion |
| Operating Income | 1.13 Billion | 966.74 Million | 1.08 Billion | 3.58 Billion | 686.91 Million | 910.11 Million |
| Interest Expense | 32.91 Million | 30.62 Million | 23.05 Million | 118.21 Million | 33.89 Million | 24.74 Million |
| Income Tax Expense | 210.94 Million | 152.39 Million | 207.94 Million | 619.58 Million | 125.02 Million | 149.28 Million |
| Earnings before Tax | 1.08 Billion | 968.11 Million | 1.1 Billion | 3.65 Billion | 820.95 Million | 902.97 Million |
| Net Income | 866.3 Million | 833.6 Million | 862.41 Million | 2.83 Billion | 649.81 Million | 755.22 Million |
| Earnings Per Share Basic | 0.49 | 0.48 | 0.49 | - | 0.37 | 0.43 |
| Earnings Per Share Diluted | 0.49 | 0.48 | 0.49 | - | 0.37 | 0.43 |
| Weighted Average Shares Outstanding | 1.75 Billion | 1.75 Billion | 1.75 Billion | 1.75 Billion | 1.75 Billion | 1.74 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.75 Billion | 1.75 Billion | 1.75 Billion | 1.75 Billion | 1.75 Billion | 1.75 Billion |
| Gross Margin | 0.32 | 0.32 | 0.32 | 0.31 | 0.32 | 0.32 |
| EBIT Margin | 0.11 | 0.11 | 0.11 | - | 0.09 | 0.09 |
| Profit Margin | 0.08 | 0.08 | 0.08 | 0.07 | 0.06 | 0.08 |
| EBITDA | 1.11 Billion | 1.18 Billion | 1.08 Billion | - | 900.06 Million | 934.76 Million |
| Earnings Before Tax Margin | 0.11 | 0.09 | 0.10 | 0.09 | 0.07 | 0.09 |
ZOG
TMG
NXGPY
SBSW
NAR
LCOMF